Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-29
DOI
10.1007/s00415-020-09848-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS
- (2019) Mathias Granqvist et al. Multiple Sclerosis Journal
- Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study
- (2018) Massimiliano Mirabella et al. CNS DRUGS
- Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study
- (2018) Giulia Mallucci et al. JOURNAL OF NEUROLOGY
- Real-life persistence and tolerability with dimethyl fumarate
- (2018) Tobias Sejbaek et al. Multiple Sclerosis and Related Disorders
- Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
- (2017) E. Havrdova et al. EUROPEAN JOURNAL OF NEUROLOGY
- Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study
- (2016) A. Miclea et al. JOURNAL OF NEUROLOGY
- Data quality evaluation for observational multiple sclerosis registries
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
- (2016) Ralf Gold et al. Multiple Sclerosis Journal
- Eosinophilic gastroenteritis in a woman with multiple sclerosis on dimethyl fumarate
- (2016) Flaminia Purchiaroni et al. NEUROLOGY
- Data quality evaluation for observational multiple sclerosis registries
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study
- (2016) Ralf Gold et al. Multiple Sclerosis Journal
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Why do we need observational studies of everyday patients in the real-life setting?: Table 1
- (2015) Alexander T. Cohen et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- A systematic review of the incidence and prevalence of cancer in multiple sclerosis
- (2014) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started